SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CICCONE, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.145
AS - Asia 2.635
EU - Europa 1.476
SA - Sud America 366
AF - Africa 52
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.683
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.028
SG - Singapore 1.005
CN - Cina 727
DE - Germania 346
VN - Vietnam 317
BR - Brasile 277
UA - Ucraina 207
IT - Italia 199
GB - Regno Unito 182
HK - Hong Kong 165
TR - Turchia 142
FR - Francia 104
FI - Finlandia 103
SE - Svezia 74
RU - Federazione Russa 71
JP - Giappone 63
CA - Canada 62
IN - India 59
BD - Bangladesh 53
MX - Messico 42
PL - Polonia 40
AR - Argentina 27
CZ - Repubblica Ceca 26
NL - Olanda 25
ES - Italia 24
BE - Belgio 21
ID - Indonesia 21
IQ - Iraq 19
ZA - Sudafrica 18
EC - Ecuador 16
LT - Lituania 16
CL - Cile 12
CO - Colombia 12
VE - Venezuela 11
PK - Pakistan 10
RO - Romania 8
AT - Austria 7
EG - Egitto 7
MA - Marocco 7
MY - Malesia 7
SA - Arabia Saudita 7
IL - Israele 6
UZ - Uzbekistan 6
AU - Australia 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
ET - Etiopia 4
IR - Iran 4
PY - Paraguay 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
KR - Corea 3
OM - Oman 3
PH - Filippine 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
HU - Ungheria 2
KG - Kirghizistan 2
LY - Libia 2
MT - Malta 2
NI - Nicaragua 2
PT - Portogallo 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
RW - Ruanda 1
SR - Suriname 1
TO - Tonga 1
Totale 9.683
Salva come PNG Salva come JPEG
Città #
Singapore 661
Ashburn 614
Woodbridge 466
Fairfield 391
San Jose 335
Houston 320
Beijing 279
Chandler 259
Jacksonville 224
Santa Clara 216
Ann Arbor 179
Seattle 160
Hong Kong 156
Cambridge 148
Wilmington 137
Los Angeles 120
New York 120
Ho Chi Minh City 96
Munich 87
Dallas 79
Hanoi 74
Nanjing 71
Izmir 70
Tokyo 57
Princeton 53
Ferrara 51
Shanghai 50
Lauterbourg 41
Boardman 40
San Diego 40
São Paulo 39
Warsaw 38
Addison 37
Milan 36
Turku 32
Buffalo 27
Helsinki 26
London 26
Montreal 26
Shenyang 26
Bremen 25
Mexico City 23
Orem 23
Brussels 21
Nanchang 20
Denver 19
Frankfurt am Main 19
Haiphong 19
Manchester 19
Stockholm 19
Da Nang 18
Poplar 18
Chennai 17
Brooklyn 15
Hebei 15
Hefei 15
Johannesburg 15
San Francisco 15
Brno 14
Chicago 13
Falkenstein 13
Amsterdam 12
Changsha 12
Jinan 12
Tianjin 12
Toronto 12
Jakarta 11
Mumbai 11
Phoenix 11
Atlanta 10
Auburn Hills 10
Augusta 10
Guangzhou 10
Moscow 10
Olomouc 10
Rio de Janeiro 10
Bologna 9
Zhengzhou 9
Baghdad 8
Biên Hòa 8
Boston 8
Council Bluffs 8
Orange 8
The Dalles 8
Ankara 7
Dearborn 7
Guayaquil 7
Hải Dương 7
Jiaxing 7
Nuremberg 7
Ottawa 7
San Mateo 7
Madrid 6
Santiago 6
Can Tho 5
Curitiba 5
Delhi 5
Falls Church 5
Lahore 5
Mountain View 5
Totale 6.609
Salva come PNG Salva come JPEG
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 290
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 279
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 268
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 266
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 262
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 254
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 248
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 243
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 241
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 239
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 237
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 237
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 229
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 228
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 225
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 220
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 219
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 218
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 218
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 217
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 212
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 206
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 206
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 205
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 201
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 201
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 200
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 199
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 192
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 191
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 190
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 185
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 184
Neoplastic circulating endothelial cells in hematologic malignancies 178
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 176
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 172
Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia 172
Molecular cytogenetic lesions in chronic lymphocytic leukemia 158
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 154
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 153
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 149
Significato dell'analisi citogenetica e citogenetico-molecolare nella diagnosi e nella prognosi delle neoplasie ematologiche. Cytogenetics and molecular cytogenetics in diagnosis and prognosis of haematological malignancies 134
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 131
TRISOMY 8 IN PDGFRB-NEGATIVE CELLS IN A PATIENT WITH IMATINIB SENSITIVE CHRONIC MYELOMONOCYTIC LEUKAEMIA AND THE T(5;16)(Q33;P13)/PDGFRB/NDE1 FUSION 131
Neoplastic circulating endothelial cells in hematologic malignancies 127
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 109
Neoplastic circulating endothelial cells in hematologic malignancies. 99
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 75
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow sample. 67
null 59
null 55
null 45
Totale 9.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 641
Totale 40.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/2022579 57 68 32 16 29 23 24 18 11 46 56 199
2022/2023562 55 31 24 69 111 73 31 55 60 5 26 22
2023/2024277 28 37 10 7 11 56 12 22 7 6 6 75
2024/20251.276 16 42 91 51 170 149 13 44 201 105 197 197
2025/20263.863 400 166 284 534 619 274 448 225 346 394 148 25
Totale 9.754